Feed JAGSNPHARM.NS
JA
Jagsonpal Pharmaceuticals Limited
JAGSNPHARM.NS · NSE
₹225.50 -2.38% (-₹5.49)
1M +0.40%
Market Cap ₹15.3B
P/E Ratio 35.45x
Div. Yield 1.72%
ROE 17.08%
Bulios Fair Price
₹161.43
28.4% downside
Preț actual
₹225.5
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile JAGSNPHARM.NS sunt în prezent supraevaluate față de prețul lor de piață. Cum funcționează?
Valuation
25 /100
Expensive P/B 5.53x
P/S 5.32x
P/E 35.45x
Growth
59 /100
Stable Book val. growth 20.23%
FCF growth 0.24%
EPS growth 15.64%
Profitability
87 /100
Strong FCF margin 16.25%
Op. margin 16.93%
Gross margin 63.66%
Quality
78 /100
Excellent Asset turnover 0.91x
ROA 13.60%
ROIC 12.56%
Debt
100 /100
Low Net debt/EBITDA -0.03x
Int. coverage 56.95x
Debt/Equity 0.03x
Stability
44 /100
Moderate Profitable years 6
EPS volatility 93.90%
Beta -0.35x
Întreabă StockBot despre JAGSNPHARM.NS
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Manish Gupta
Employees
1,025
Headquarters
Gurugram
Evenimente viitoare
04 SEPT.
Ex-Dividend
Ex-dividend date
04 SEPT.
Dividend Payment
Data plății